Alpha 2.0
Login Register
» Articles » PMID: 743489

Clinical Response and Plasma Levels of 5-fluorouracil in Patients with Colonic Cancer Treated by Drug Infusion

Overview
Journal Br J Cancer
Specialty Oncology
Date 1978 Dec 1
PMID 743489
Citations 32
Authors
B L HILLCOAT
P B McCulloch
A T Figueredo
M H Ehsan
J M Rosenfeld
Affiliations
Soon will be listed here.
Abstract

Concentrations of 5-fluorouracil (FU) were measured in the plasma of patients receiving i.v. infusions of the drug for 5 days as treatment for adenocarcinoma of the gastrointestinal tract. Concentrations of FU varied widely in many patients. Concentration of drug X time of infusion (C X t values) were calculated. Patients showing a partial response or stabilization of disease had significantly higher C X t values than non-responders. Methyl CCNU did not affect the C X t values of FU. Determination of the plasma concentration of FU would allow the dose of the drug to be adjusted to maintain high concentrations of FU in the plasma. Our data suggest that such high concentrations would increase the response rate in this disease.

Citing Articles

Therapeutic drug monitoring for cytotoxic anticancer drugs: Principles and evidence-based practices.

Smita P, Narayan P, J K, Gaurav P Front Oncol. 2022; 12:1015200.

PMID: 36568145 PMC: 9773989. DOI: 10.3389/fonc.2022.1015200.

High-dose chemotherapy for relapsed testicular germ cell tumours.

Chovanec M, Adra N, Zaid M, Abonour R, Einhorn L Nat Rev Urol. 2022; 20(4):217-225.

PMID: 36477219 DOI: 10.1038/s41585-022-00683-1.

and Fluorouracil-Based Chemotherapy: Mini Review and Case Report.

Wigle T, Tsvetkova E, Welch S, Kim R Pharmaceutics. 2019; 11(5).

PMID: 31052357 PMC: 6572291. DOI: 10.3390/pharmaceutics11050199.

Therapeutic Drug Monitoring in Oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology Recommendations for 5-Fluorouracil Therapy.

Beumer J, Chu E, Allegra C, Tanigawara Y, Milano G, Diasio R Clin Pharmacol Ther. 2018; 105(3):598-613.

PMID: 29923599 PMC: 6309286. DOI: 10.1002/cpt.1124.

Pharmacokinetically guided algorithm of 5-fluorouracil dosing, a reliable strategy of precision chemotherapy for solid tumors: a meta-analysis.

Fang L, Xin W, Ding H, Zhang Y, Zhong L, Luo H Sci Rep. 2016; 6:25913.

PMID: 27229175 PMC: 4882511. DOI: 10.1038/srep25913.

References
1.
Clarkson B, OConnor A, WINSTON L, Hutchison D . THE PHYSIOLOGIC DISPOSITION OF 5-FLUOROURACIL AND 5-FLUORO-2'-DEOXYURIDINE IN MAN. Clin Pharmacol Ther. 1964; 5:581-610. DOI: 10.1002/cpt196455581. View
2.
WOOLLEY 3rd P, Macdonald J, Schein P . Chemotherapy of colorectal carcinoma. Semin Oncol. 1976; 3(4):415-20. View
3.
HILLCOAT B, Banerjee M, McCulloch P, Williams C . Prediction of marrow toxicity in patients treated by intravenous infusion of 5 fluorouracil. Eur J Cancer (1965). 1977; 13(1):81-7. DOI: 10.1016/0014-2964(77)90233-x. View
4.
HILLCOAT B, Kawai M, McCulloch P, Rosenfeld J, Williams C . A sensitive assay of 5-fluorouracil in plasma by gas chromatography-mass spectrometry. Br J Clin Pharmacol. 1976; 3(1):135-43. PMC: 1428807. DOI: 10.1111/j.1365-2125.1976.tb00580.x. View
5.
Cohen J, IRWIN L, Marshall G, Darvey H, Bateman J . Clinical pharmacology of oral and intravenous 5-fluorouracil (NSC-19893). Cancer Chemother Rep. 1974; 58(5 Pt 1):723-31. View